Discover how gut microbiota modulation enhances CAR-T cell therapy effectiveness in cancer treatment through antigen cross-presentation and immune activation.
Explore how scientists are rewiring Natural Killer (NK) cells to enhance their natural cancer-killing abilities, potentially revolutionizing cancer treatment.
Exploring how nucleolar antigens in cancer cells reveal new pathways for diagnostics and immunotherapy, focusing on NPM1, NOL9, and B23 proteins.
Discover groundbreaking research on identifying tumor-associated antigens expressed on tumor cell surfaces, opening new avenues for cancer immunotherapy.
Explore Onxeo's OX401, a novel PARP agonist with dual anti-tumor and immunological properties that could transform cancer treatment approaches.
Explore how immune profiling technologies are revolutionizing cancer drug development and personalized immunotherapy treatments.
Explore how adoptive cell therapy revolutionizes cancer treatment by reprogramming immune cells as living drugs to fight cancer with unprecedented precision.